Advocates Applaud Panel Recommendation and Look Forward to Health Commissioner’s Decision
New Jersey Should Join Other States That Allow Medical Marijuana for Chronic Pain
Trenton, NJ— Today, the New Jersey Medicinal Marijuana Program Review Panel made initial recommendations to the Health Commissioner to approve chronic pain related to musculoskeletal disorders, migraines, anxiety, chronic fatigue related to ailments such as irritable bowel syndrome, Tourrette syndrome as qualifying conditions for the medical marijuana program.
May 11, 2017
Drug Policy Alliance
Read article here: Drug Policy Alliance – Medical Marijuana